Literature DB >> 27682006

Allogeneic Blood Transfusion Is a Significant Risk Factor for Surgical-Site Infection Following Total Hip and Knee Arthroplasty: A Meta-Analysis.

Jeong Lae Kim1, Jong-Hoon Park1, Seung-Beom Han1, Il Youp Cho1, Ki-Mo Jang1.   

Abstract

BACKGROUND: Blood loss occurs significantly more frequently during total hip and knee arthroplasty than among any other type of orthopedic operation, which can sometimes lead to requiring a blood transfusion. Although allogeneic blood transfusion has been identified as a risk factor for postoperative surgical-site infection following arthroplasty, results are inconclusive. The purpose of this study was to conduct a systematic meta-analysis to investigate whether having an allogeneic blood transfusion significantly increases the risk for surgical-site infection, particularly after total hip and knee arthroplasty.
METHODS: We performed a systematic review and meta-analysis using random-effect models. Using an electronic database search, we selected 6 studies that included data on 21,770 patients and among these studies compared the postoperative infection rate between an allogeneic blood-transfusion exposure group and a nonexposure group. We calculated the pooled odds ratios and 95% confidence intervals for the groups.
RESULTS: The prevalences of surgical-site infections in our pooled analyses were 2.88% and 1.74% for the transfusion and nontransfusion groups, respectively. The allogeneic blood transfusion group had a significantly higher frequency of surgical-site infections based on pooled analysis using a random-effect model (pooled odds ratio = 1.71, 95% confidence interval: 1.23-2.40, P = .002).
CONCLUSION: Allogeneic blood transfusion is a significant risk factor for increasing the surgical-site infection rate after total hip and knee arthroplasty.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  allogeneic blood transfusion; meta-analysis; surgical-site infection; total hip arthroplasty; total knee arthroplasty

Mesh:

Year:  2016        PMID: 27682006     DOI: 10.1016/j.arth.2016.08.026

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  42 in total

1.  A prospective randomized trial of total synovectomy versus limited synovectomy in primary total knee arthroplasty: evaluation of bleeding, postoperative pain, and quality of life with SF-12 v2.

Authors:  Luis Dario Bernal-Fortich; Carlos Alberto Aguilar; Adrián H Rivera-Villa; Joel Galindo-Avalos; Pedro Aguilera-Martínez; Rubén Torres-González; Avelino Colin-Vázquez
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-01-30

2.  Hemostatic effect of tourniquet combined with tranexamic acid in total knee arthroplasty: a network meta-analysis.

Authors:  Yimin Zhang; Bao Lang; Guifeng Zhao; Fengming Wang
Journal:  J Orthop Surg Res       Date:  2020-11-12       Impact factor: 2.359

3.  Continued decline in blood collection and transfusion in the United States-2015.

Authors:  Katherine D Ellingson; Mathew R P Sapiano; Kathryn A Haass; Alexandra A Savinkina; Misha L Baker; Koo-Whang Chung; Richard A Henry; James J Berger; Matthew J Kuehnert; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2017-06       Impact factor: 3.157

4.  Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial.

Authors:  HaiYan Zhao; MaoYing Xiang; YaYi Xia; Xiaojun Shi; Fu-Xing Pei; PengDe Kang
Journal:  Int Orthop       Date:  2018-02-28       Impact factor: 3.075

5.  Risk factors for infection, revision, death, blood transfusion and longer hospital stay 3 months and 1 year after primary total hip or knee arthroplasty.

Authors:  Chanseok Rhee; Lynn Lethbridge; Glen Richardson; Michael Dunbar
Journal:  Can J Surg       Date:  2018-06       Impact factor: 2.089

6.  Are The Applications of Tranexamic Acid in Reverse Hybrid Total Knee Arthroplasty (TKA) The Same as Those in Fully Cemented TKA?: A Randomized Controlled Trial.

Authors:  Shenqi Zhang; Fengyan Wang; Chengbin Wang; Pengfei Chu; Lei Shi; Qingyun Xue
Journal:  Adv Ther       Date:  2021-04-08       Impact factor: 3.845

Review 7.  [Prevention of postoperative infections : Risk factors and the current WHO guidelines in musculoskeletal surgery].

Authors:  Christian Willy; Hayo Rieger; Marcus Stichling
Journal:  Unfallchirurg       Date:  2017-06       Impact factor: 1.000

8.  Administration of Tranexamic Acid Improves Long-Term Outcomes in Total Knee Arthroplasty.

Authors:  Nicholas P Drain; Valerie C Gobao; Dominique M Bertolini; Clair Smith; Neel B Shah; Scott D Rothenberger; Malcolm E Dombrowski; Michael J O'Malley; Brian A Klatt; Brian R Hamlin; Kenneth L Urish
Journal:  J Arthroplasty       Date:  2020-03-04       Impact factor: 4.757

9.  Efficacy of topical tranexamic acid within a blood-saving programme for primary total hip arthroplasty: a pragmatic, open-label randomised study.

Authors:  Nuria Pérez-Jimeno; Manuel Muñoz; Jesús Mateo; Ana P Mayoral; Antonio Herrera
Journal:  Blood Transfus       Date:  2018-09-03       Impact factor: 3.443

10.  Postoperative hemoglobin and recovery of hip muscle strength after total hip arthroplasty.

Authors:  Katsuhiko Maezawa; Masahiko Nozawa; Takahito Yuasa; Motosi Gomi; Emi Igarashi; Hironobu Sato; Munehiko Sugimoto; Kazuo Kaneko
Journal:  J Orthop       Date:  2018-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.